Ilia Dereven'kov

Dr. Ilia Dereven'kov

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Macroheterocycles
Verified
Journal Article
Closed access
Oscar I. KoifmanOscar I. Koifman
Oscar I. Koifman
TATatyana A. Ageeva
Tatyana A. Ageeva
Irina Petrovna  BeletskayaIrina Petrovna Beletskaya
Irina Petrovna Beletskaya
AAAlexei D. Averin
Alexei D. Averin
AYAlexei A. Yakushev
Alexei A. Yakushev
EYElena S. Yurina
Elena S. Yurina

1 August 2013 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
IDIlia Dereven'kov
Ilia Dereven'kov
DSDenis S. Salnikov
Denis S. Salnikov
SMSergei V. Makarov
Sergei V. Makarov
MSMihai Surducan
Mihai Surducan
Radu Silaghi-DumitrescuRadu Silaghi-Dumitrescu
Radu Silaghi-Dumitrescu
GBGerry R. Boss
Gerry R. Boss

18 August 2022 in iScience
Verified
Journal Article
Open access
AEAnna J. Esser
Anna J. Esser
SMSrijan Mukherjee
Srijan Mukherjee
IDIlia Dereven'kov
Ilia Dereven'kov
SMSergei V. Makarov
Sergei V. Makarov
DJDonald W. Jacobsen
Donald W. Jacobsen
Luciana HannibalLuciana Hannibal
Luciana Hannibal
Nutritional deficiency and genetic errors that impair the transport, absorption, and utilization of vitamin B12 (B12) lead to hematological and neurological manifestations. The cblC disease (cobalamin complementation type C) is an autosomal recessive disorder caused by mutations and epi-mutations in the MMACHC gene and the most common inborn error of B12 metabolism. Pathogenic mutations in MMACHC disrupt enzymatic processing of B12, an indispensable step before micronutrient utilization by the two B12-dependent enzymes methionine synthase (MS) and methylmalonyl-CoA mutase (MUT). As a result, patients with cblC disease exhibit plasma elevation of homocysteine (Hcy, substrate of MS) and methylmalonic acid (MMA, degradation product of methylmalonyl-CoA, substrate of MUT). The cblC disorder manifests early in childhood or in late adulthood with heterogeneous multi-organ involvement. This review covers current knowledge on the cblC disease, structure–function relationships of the MMACHC protein, the genotypic and phenotypic spectra in humans, experimental disease models, and promising therapies.

2 January 2014 in European Journal of Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
DSDenis S. Salnikov
Denis S. Salnikov
PKPolina N. Kucherenko
Polina N. Kucherenko
IDIlia Dereven'kov
Ilia Dereven'kov
SMSergei Makarov
Sergei Makarov
RERudi van Eldik
Rudi van Eldik

1 July 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
JMJoanna Myszkowska
Joanna Myszkowska
IDIlia Dereven'kov
Ilia Dereven'kov
SMSergei Makarov
Sergei Makarov
USUte Spiekerkötter
Ute Spiekerkötter
Luciana HannibalLuciana Hannibal
Luciana Hannibal
Hydrogen sulfide (H2S) is a gasotransmitter and the smallest signaling thiol metabolite with important roles in human health. The turnover of H2S in humans is mainly governed by enzymes of sulfur amino acid metabolism and also by the microbiome. As is the case with other small signaling molecules, disease-promoting effects of H2S largely depend on its concentration and compartmentalization. Genetic defects that impair the biogenesis and catabolism of H2S have been described; however, a gap in knowledge remains concerning physiological steady-state concentrations of H2S and their direct clinical implications. The small size and considerable reactivity of H2S renders its quantification in biological samples an experimental challenge. A compilation of methods currently employed to quantify H2S in biological specimens is provided in this review. Substantial discrepancy exists in the concentrations of H2S determined by different techniques. Available methodologies permit end-point measurement of H2S concentration, yet no definitive protocol exists for the continuous, real-time measurement of H2S produced by its enzymatic sources. We present a summary of available animal models, monogenic diseases that impair H2S metabolism in humans including structure-function relationships of pathogenic mutations, and discuss possible approaches to overcome current limitations of study.

12 August 2013 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
IDIlia Dereven'kov
Ilia Dereven'kov
DSDenis S. Salnikov
Denis S. Salnikov
SMSergei Makarov
Sergei Makarov
GBGerry R. Boss
Gerry R. Boss
OKOskar I. Koifman
Oskar I. Koifman
We studied the kinetics of reactions of cob(I)alamin and cob(I)inamide with thiosulfate, sulfite, and dithionite by UV-Visible (UV-Vis) and stopped-flow spectroscopy. We found that the two Co(I) species were oxidized by these sulfur-containing compounds to Co(II) forms: oxidation by excess thiosulfate leads to penta-coordinate complexes and oxidation by excess sulfite or dithionite leads to hexa-coordinate Co(II)–SO2 − complexes. The net scheme involves transfer of three electrons in the case of oxidation by thiosulfate and one electron for oxidation by sulfite and dithionite. On the basis of kinetic data, the nature of the reactive oxidants was suggested, i.e., HS2O3 − (for oxidation by thiosulfate), S2O5 2−, HSO3 −, and aquated SO2 (for oxidation by sulfite), and S2O4 2− and SO2 − (for oxidation by dithionite). No difference was observed in kinetics with cob(I)alamin or cob(I)inamide as reductants.